Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stem cells fill gap left by stroke

27.07.2004


A stroke leaves a permanent gap in the brain that can destroy a person’s ability to speak and move normally. Filling that gap with new cells has been a long sought-after goal of stem cell research, but all attempts have met with complications - until now. Researchers at Stanford University School of Medicine report the first success using stem cells to populate the damaged region with new neurons in rats. If those cells also replace the function of the lost cells, they could help people recover after a stroke.



In the study, published in the July 26 advance online issue of Proceedings of the National Academies of Science, neurosurgeon Gary Steinberg, MD, PhD, and his group found that fetal stem cells injected into the brains of rats could migrate to the right location and turn into the appropriate types of neurons. "We’re not saying we can treat patients immediately, but it’s a big step forward. This gives us considerable optimism for these cells," Steinberg said.

The cells in question are at an early stage of developing into the mature brain and are still able to form many types of brain cells, but until now the cells have shown that potential only in a lab dish. Stem Cells Inc., a company founded by study co-author and pathology professor Irving Weissman, MD, reported isolating these cells from human fetal tissue in December 2000. The company now grows the cells in bulk and distributes them to researchers studying spinal cord injuries as well as Parkinson’s, Alzheimer’s and other brain disorders. Steinberg’s is the first paper to show that the cells can transform into the appropriate cell types in an animal.


Steinberg said the fetal cells, called neurospheres, have advantages over both adult and embryonic stem cells for treating stroke. Adult brain stem cells produce new neurons throughout a person’s life. After a stroke, these cells seem to repair some damage but aren’t able to completely compensate for the lost tissue. In animal experiments, Steinberg’s group has found that additional adult neuronal stem cells injected into the brains of rats may not survive long or migrate to the correct location.

Human embryonic stem cells have a different set of problems. Although embryonic stem cells show promise for treating rats with strokes, the human cells aren’t widely available for research due to federal restrictions and aren’t approved for use in humans. Even if the cells effectively treated stroke damage in rats, Steinberg couldn’t offer that treatment to patients.

Fetal cells share the benefits of adult and embryonic cells without the drawbacks. This early study suggests that they will be more effective at treating stroke than adult cells. The cells are also available for research and are grown according to FDA-regulated Good Manufacturing Practice standards, unlike their human embryonic counterparts. This means the cells have already passed one FDA hurdle and could move to clinical trials in humans if Steinberg’s follow-up experiments are successful.

Steinberg warns that this study did not look at whether fetal neurospheres helped rats recover brain function after a stroke. Instead, he and co-first authors Tonya Bliss, PhD, a research associate, and Steven Kelly, PhD, now at the University of Bristol, wanted to determine whether the cells migrated to the right place and turned into the right kind of cell. When stem cells were injected close to the site of the induced stroke, the cells survived in only one out of nine mice. Steinberg said this makes sense because the stroke site doesn’t have a blood supply to keep the cells alive.

However, when injected a few millimeters away, the cells survived and migrated as far as 1.2 millimeters toward the stroke region. Steinberg believes signals from the damaged cells act as a distress call beckoning the transplanted cells. Other signals direct the newly arrived cells to transform into neurons and support cells called astrocytes. In rats without an induced stroke, the injected cells migrated only an average of 0.2 millimeters.

"The next step is to show recovery," Steinberg said. His group examined the transplanted cells after only four weeks, too soon to know whether the cells can help the rats recover. In the next set of experiments they will study whether the neurospheres help the rats recover normal movement after the stroke.

Michael Marks, MD, associate professor of radiology and a faculty member at the Stanford Stroke Center, said he is encouraged by Steinberg’s findings. Marks said there is currently no way to treat patients who have lost brain function after a stroke. "This would be a very important therapeutic tool for us to have," he said, adding that existing treatments are only effective in the first few hours after the stroke. Most patients don’t arrive at the hospital within that window and therefore have no options for reducing damage to their brain cells. "A therapy like this has tremendous potential," he said.

Every 45 seconds an American has a stroke, for a total of about 700,000 strokes per year. It is the leading cause of serious, long-term disability in the United States. Most strokes are caused by blood clots blocking vessels in the brain, cutting off the supply of oxygen and nutrients to brain cells. The remaining 12 percent of strokes occur when blood vessels burst and leak blood into the brain. Strokes are the third most common cause of death after heart disease and cancer.

Amy Adams | EurekAlert!
Further information:
http://www.stanford.edu

More articles from Life Sciences:

nachricht A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich

nachricht New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>